Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Conway Charles | Chief Scientific Officer | Oct 03, 2022 | Option Exercise | $148.50 | 22,362 | 3,320,757 | 0 | Oct 03, 2022, 08:23 PM | |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Conway Charles | Chief Scientific Officer | Jan 06, 2022 | Option Exercise | $123.86 | 1,800 | 222,948 | 22,135 | Jan 07, 2022, 09:18 PM | |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Conway Charles | Chief Scientific Officer | Nov 23, 2021 | Option Exercise | $36.18 | 10,885 | 393,799 | 16,897 | Nov 26, 2021, 04:26 PM | |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Conway Charles | Chief Scientific Officer | Jan 06, 2021 | Option Exercise | $83.38 | 1,747 | 145,665 | 10,012 | Jan 08, 2021, 08:48 PM | |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Conway Charles | Chief Scientific Officer | Nov 25, 2020 | Option Exercise | $90.14 | 1,361 | 122,681 | 7,278 | Nov 27, 2020, 09:47 PM | |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Conway Charles | Chief Scientific Officer | Dec 18, 2019 | Option Exercise | $52.13 | 1,361 | 70,949 | 5,639 | Dec 20, 2019, 09:42 PM | |
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Conway Charles | Chief Scientific Officer | May 09, 2017 | Buy | $17.00 | 4,000 | 68,000 | 4,000 | May 11, 2017, 05:00 PM |